- Evolving Strategies for Myelofibrosis-Associated Anemia Highlight Persistent Gaps in Biomarker GuidanceAaron Gerds, MD, MS, and Anthony M. Hunter, MD, break down the challenges of anemia management in myelofibrosis and potential treatment avenues.onclive · 2mo ago↗ source
- Perioperative Durvalumab Plus Neoadjuvant EV Displays EFS, OS Benefits vs SOC in MIBCPerioperative durvalumab plus EV showed positive topline efficacy findings in MIBC.onclive · 2mo ago↗ source
- Rintatolimod Plus Pembrolizumab and Cisplatin Displays 50% ORR in Recurrent Ovarian CancerThe addition of rintatolimod to pembrolizumab and cisplatin demonstrated robust albeit preliminary antitumor activity in patients with recurrent ovarian cancer.